Ketozolin 2%

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ketozolin 2%

Quick Facts

Property Description
Active Ingredient Ketoconazole (20 mg/g)
Form Aqueous suspension shampoo
Pharmacological Class Azole Antifungal
General Purpose Targeting fungal skin infections
Origin Synthetic, imidazole-dioxolane derivative

Defining Ketozolin 2% and its Pharmacological Class

Ketozolin 2% is a medicinal preparation classified as a broad-spectrum azole antifungal agent intended for topical administration to the skin and scalp. Its sole active component is Ketoconazole, a potent synthetic compound derived from the imidazole-dioxolane structure. This preparation is defined as a monopreparation and is clinically recognized for its reliable efficacy within the antifungal therapy domain. The designation as an azole antifungal places it within a core group of anti-infective agents recognized for their documented efficacy against a range of fungal organisms.

Composition and Pharmaceutical Form: The 2% Aqueous Suspension

The physical form of Ketozolin 2% is an aqueous suspension shampoo, which is a liquid dosage form designed for targeted application. This suspension contains a precise 2% concentration of Ketoconazole, equating to 20 mg/g of the active ingredient delivered within the vehicle base. The 20 mg/g formulation is the established concentration for this product's purpose as an antifungal agent, confirmed by regulatory bodies. This specific shampoo format represents a key differentiating feature, optimizing delivery for conditions prevalent across hair-bearing areas, unlike simpler cream or gel formulations.

General Purpose of This Anti-Infective Agent

The general purpose of Ketozolin 2% is to interrupt the progression of fungal infections by acting directly on the pathogen's structure. The preparation utilizes Ketoconazole's ability to inhibit ergosterol synthesis, a vital process unique to the fungal cell membrane. This mechanism renders the preparation an effective anti-infective measure generally used to address skin diseases caused by susceptible fungal and yeast pathogens, a typical scenario being the management of conditions affecting the scalp.

What side effects are possible with Ketozolin 2%?

Possible Side Effects and Safety Information

The safety profile for Ketozolin 2% shampoo, based on regulatory documentation, is characterized by local and typically infrequent adverse reactions. The official data indicates that the most common effects occur with an incidence rate of less than 1%, placing them in the Uncommon classification (affecting up to 1 in 100 people) or Rare (affecting up to 1 in 1,000 people).

Adverse reactions are primarily associated with the application site, classified by regulatory authorities within the Skin and subcutaneous tissue disorders and General disorders and administration site conditions system classes.

Officially Documented Adverse Reactions

Classification Examples of Reactions (Uncommon/Rare)
Application Site Reactions Application site pruritus (itching), burning sensation, irritation, erythema (redness), and pustules.
Dermatological Effects Dry skin, folliculitis, abnormal hair texture, rash, and changes in hair colour.
Serious Reactions Severe systemic responses, though rare, include Angioedema and Hypersensitivity reactions.

Key Safety Considerations

The product is strictly contraindicated in any individual who has a known hypersensitivity to the active substance, Ketoconazole, or any excipients in the formulation.

Regulatory safety notes indicate that plasma concentrations of ketoconazole are generally non-detectable following chronic topical application to the scalp. This minimal systemic absorption provides the context for safety considerations when used in populations such as pregnant or lactating individuals. Use near the eyes should be avoided as the product may be irritating to mucous membranes.

Overdose and Emergency Response

The official regulatory guidance for Ketozolin 2% shampoo addresses the specific scenario of overdose, which is defined primarily by accidental oral ingestion of the product. The product is intended for topical application, and systemic toxicity is not anticipated from intended use on the skin or scalp. All emergency actions detailed by regulatory authorities are focused strictly on managing ingestion and its potential risks.

When to Seek Immediate Medical Help

Urgent medical intervention is required if accidental ingestion is known or suspected. Users must immediately contact a poison control center or seek emergency medical attention. Immediate emergency services must be contacted if the affected individual displays serious symptoms such as passing out (loss of consciousness) or experiences trouble breathing (respiratory distress).

Official Management Procedures

Management procedures, as documented in regulatory labeling, rely on the administration of supportive and symptomatic measures. A critical regulatory instruction is the explicit prohibition of certain interventions: neither emesis (inducing vomiting) nor gastric lavage should be instigated. This procedural restriction is mandated to prevent the serious risk of aspiration into the lungs. Furthermore, official labeling confirms that no specific antidote is known for Ketoconazole overdose, underscoring the necessity of comprehensive supportive care.

Therapeutic Uses of Ketozolin 2%

What Ketozolin 2% Treats: Main Uses and Benefits

Ketozolin 2% shampoo is a medicinal treatment used for managing specific fungal and yeast infections of the skin and scalp, focusing on symptomatic relief and may be part of symptomatic management for recurrence. The therapy supports conditions where fungal overgrowth is the primary driver of patient discomfort.

This topical treatment is commonly used for conditions marked by excessive scaling and flaking, specifically Seborrhoeic Dermatitis, significant Pityriasis Capitis (dandruff), and Pityriasis Versicolor (Tinea Versicolor).

It is applied in contexts where additional support for symptom management is needed, contributing to improved day-to-day comfort during symptomatic periods. The treatment supports relief for distressing manifestations such as persistent itching (pruritus), localized redness, and the presence of noticeable scaling. The shampoo assists with maintaining functional stability by contributing to easing the overall symptom load.


Quick Fact: Relief for Pruritus and Scaling

Ketozolin 2% is relevant for easing symptoms that interfere with daily comfort, particularly the intense itching and the visible flaking associated with the fungal overgrowth on the scalp and body.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Status

Classification Who Can or Cannot Use
Absolute Contraindication Individuals with known hypersensitivity to the active ingredient, ketoconazole, or to any of the formulation's excipients are strictly prohibited from use, as this is a formal regulatory exclusion.
Indicated Age Groups Use is officially indicated for Adults and Adolescents (typically 12 years of age and older).
Use Not Established Safety and effectiveness have not been established for children under 12 years; therefore, use is not recommended in this age group based on regulatory documentation.

Special Population Constraints

Conditional Status Regulatory Statement
Topical Steroid Users Patients on prolonged topical corticosteroids must follow a protocol for gradual withdrawal of the steroid while commencing shampoo use to mitigate the risk of a rebound effect.
Pregnancy/Lactation Eligibility is conditional. Regulatory information notes that the topical shampoo results in undetectable plasma concentrations, minimizing systemic exposure, but official caution is still advised during pregnancy and lactation.
Organ Impairment No specific restrictions are documented for the topical shampoo based on hepatic or renal impairment due to the product’s minimal systemic absorption into the bloodstream.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ketozolin 2% shampoo, which contains ketoconazole, has a specialized interaction profile governed by its topical administration and minimal systemic absorption. Official regulatory assessments confirm that the active ingredient is typically not detected in plasma after chronic use on the scalp.


Systemic Drug-Drug Interaction Status

Interaction Type Regulatory Status (Topical 2% Shampoo)
Pharmacokinetic Interactions (e.g., CYP enzymes) None documented. Systemic interaction is considered unlikely due to the absence of detectable plasma concentrations, which would otherwise drive metabolic interactions.
Contraindicated Combinations None documented. No specific oral medicines are prohibited for co-administration based on the topical product's effect.

Administration-Timing Interaction Rules

While systemic interactions are not documented, regulatory labeling includes a mandatory administration-timing rule for a specific product class:

  • Topical Corticosteroids: If an individual has been on prolonged treatment with topical corticosteroids, the regulatory documents stipulate that the steroid therapy must be gradually withdrawn over a period of 2 to 3 weeks while commencing use of the shampoo. This requirement is intended to prevent a localized cutaneous rebound effect upon sudden steroid cessation.

Regulatory documentation confirms that interaction studies have not been performed, and no other restrictions regarding food, alcohol, or supplements are documented for this topical formulation.

Mechanism of Action

Inhibition of Fungal Cell Membrane Synthesis

The action of Ketozolin 2% (Ketoconazole) involves the inhibition of the fungal enzyme Cytochrome P450 14α-Demethylase (CYP51A1), which is essential for manufacturing ergosterol, the fundamental sterol required for yeast cell membranes. By blocking this specific metabolic step, the drug causes the structural integrity and function of the pathogen's membrane to collapse, leading to a fungistatic effect and resulting in the inhibition of fungal growth and proliferation.

️ Local Anti-Inflammatory Pathway Modulation

Independent of its fungistatic action, Ketoconazole engages mechanisms that directly modulate local cutaneous inflammatory mediators in the skin tissue. This activity involves the modulation of local physiological signaling associated with inflammation. This separate mechanism produces an attenuation of tissue inflammation at a rate governed by mediator kinetics, distinct from the mycological clearance rate.

Constraints and Strictly Localized Action

The full mechanistic effect is localized to the skin and associated structures (peripheral action) due to the drug's topical administration and minimal systemic absorption. The fungistatic mechanism is highly targeted to organisms that rely on the CYP51A1/Ergosterol pathway and is susceptible to biological evasion mechanisms like acquired resistance or efflux pumps.

Dosage and Administration Information

Official Administration Guidelines for Ketozolin 2% Shampoo

Ketozolin 2% shampoo is for topical administration to the affected skin and scalp. This prescription-strength medication must be used according to the official instructions for adults and adolescents. Safety and effectiveness in children have not been established.

Application Procedure

  1. Wet the hair and/or affected area of the skin thoroughly with water.
  2. Apply sufficient shampoo to produce a lather, covering the affected skin area and a wide margin surrounding it.
  3. Gently massage the shampoo into the area.
  4. Leave the shampoo in place for 3 to 5 minutes.
  5. Rinse the area thoroughly with water.

Official Dosing Schedule

The required frequency and duration depend on the condition being addressed:

Condition Treatment Regimen Prophylaxis Regimen
Seborrhoeic Dermatitis/Dandruff Twice weekly for 2–4 weeks. Once every 1–2 weeks.
Pityriasis Versicolor (Tinea Versicolor) Once daily for a maximum of 5 days or a single application. Once daily for a maximum of 3 days before sun exposure.

Special Conditions

Corticosteroid Transition: Patients using prolonged topical corticosteroids should gradually withdraw the steroid therapy over a 2–3 week period while initiating the shampoo. This prevents a potential rebound effect upon abrupt steroid cessation.

Eyes and Mucous Membranes: Avoid contact with the eyes. If the shampoo enters the eyes, they should be bathed gently and thoroughly with water.

Recent Clinical Evidence

Ketozolin 2%: Recent Clinical Evidence


Therapeutic Use Profile

Ketozolin 2% contains the active ingredient ketoconazole, an antifungal agent. Clinical evidence supports its use in managing conditions associated with fungal overgrowth. The primary conditions for which the 2% formulation has been studied include seborrheic dermatitis and pityriasis versicolor (also known as tinea versicolor).

Research has explored the drug's activity in regulating symptoms associated with these dermatological conditions.


Efficacy in Seborrheic Dermatitis

Controlled trials have investigated the application of ketoconazole 2% in adults diagnosed with moderate to severe seborrheic dermatitis. Studies focused on changes in the following primary endpoints:

  • Reduction of scaling and flaking on the scalp.
  • Changes in associated symptoms like pruritus (itching).
  • Overall investigator's assessment of clinical improvement.

Consistent findings across multiple studies indicated an observed trend toward improvement in scalp condition and a reduction in symptom severity over the treatment period compared to placebo or baseline measurements. Specific study protocols evaluated twice-weekly application regimens over a four-week period.


Evidence for Pityriasis Versicolor

For pityriasis versicolor, research has examined shorter treatment protocols, typically involving daily application for a fixed duration. The primary endpoint for these trials was achieving mycological cure, meaning the absence of the causative organism, Malassezia furfur, in skin scrapings.

Trials documented that treatment regimens were associated with mycological clearance in a significant percentage of study participants. Studies also reported that observable changes in skin pigmentation associated with the condition may require a longer duration to fully normalize after the cessation of treatment.

Frequently Asked Questions (FAQ)

Common questions about Ketozolin 2% (FAQ)

Q: What is the difference between Ketozolin 2% and general ketoconazole shampoo?

Ketozolin 2% is a medicinal preparation that contains a 2% concentration of the active ingredient ketoconazole. This specific formulation is defined in regulatory documents as prescription-strength for managing certain skin and scalp conditions. Other products containing the same active ingredient may be available in lower concentrations as non-prescription or over-the-counter products.

Q: Can Ketozolin 2% cause temporary hair thinning or hair loss?

Studies and official documents indicate that hair loss or temporary thinning, referred to medically as alopecia, has been reported as an adverse reaction in some users. This side effect is sometimes classified as an uncommon or post-marketing event based on regulatory surveillance data.

Q: How long does it typically take to see a noticeable improvement from using Ketozolin 2%?

The time needed to see a noticeable improvement can vary depending on the condition being addressed. For seborrhoeic dermatitis, the typical treatment course is usually prescribed for 2 to 4 weeks. For conditions like tinea versicolor, visible normalization of skin pigment may take several months even after the fungal infection has successfully cleared.

Q: What is the maximum duration of continuous use for which Ketozolin 2% has been studied?

Official guidelines specify regimens for both active treatment and prophylaxis (maintenance). The maximum recommended continuous use for active treatment of seborrhoeic dermatitis is typically twice weekly for up to 4 weeks. Prophylaxis regimens, which are used for longer-term maintenance, involve less frequent application, such as once every 1 to 2 weeks.

Q: Is Ketozolin 2% effective against different types of fungal organisms?

According to the official product information, the active ingredient is classified as a broad-spectrum antifungal agent. This means it is effective against various dermatophytes and yeasts. The susceptibility profile includes common organisms such as Candida species and Malassezia furfur.

Q: Is Ketozolin 2% suitable for people who have sensitive skin in general?

Local skin reactions are commonly reported in official documents when using topical products. Regulatory information notes that application may cause reactions such as irritation, a burning sensation, redness (erythema), and dry skin. It is also noted that some of the inactive ingredients, known as excipients, may potentially cause contact dermatitis in sensitive individuals.

Q: Is Ketozolin 2% used to treat athlete's foot or ringworm?

The 2% shampoo formulation has official indications only for seborrheic dermatitis and pityriasis versicolor. While the active ingredient (ketoconazole) is used in other forms (like creams) to treat conditions such as tinea pedis (athlete’s foot) and tinea corporis (ringworm), the shampoo itself is not officially indicated for these conditions.

Q: Can Ketozolin 2% be used on areas other than the scalp and trunk?

The official guidelines state that the medication is for topical administration to the affected skin and scalp. For the conditions officially indicated, this application area may include the trunk, neck, arms, and upper thighs, wherever the affected skin is present.

Q: What signs or symptoms should prompt me to seek immediate medical attention?

Signs of a severe allergic reaction, also known as hypersensitivity, are classified as rare but serious in official documents. These reactions may include difficulty breathing or severe swelling of the face, lips, tongue, or throat (angioedema). Regulatory information strongly suggests seeking professional medical evaluation for these symptoms.

Q: Where can I find the official patient information leaflet for Ketozolin 2%?

Official patient information, such as the Patient Information Leaflet (PIL) or the Summary of Product Characteristics (SmPC), is published by government regulatory authorities. These documents are generally found on the websites of bodies like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).

Q: Are there any known long-term side effects associated with the use of Ketozolin 2%?

Long-term use on the scalp for up to six months has been evaluated in safety trials. The systemic concerns, such as liver injury, which are associated with the oral tablet form of ketoconazole, are not demonstrated to be associated with the topical shampoo. This is supported by evidence of minimal systemic absorption into the bloodstream.

Q: What happens if a person forgets to apply Ketozolin 2% at the scheduled time?

Official patient instructions regarding a missed dose state that application may be made as soon as it is remembered. However, if it is almost time for the next scheduled dose, regulatory guidance suggests skipping the missed dose and resuming the regular dosing schedule.

Q: Is it safe to use Ketozolin 2% on hair that is colored or chemically treated?

Regulatory information does include reports that the use of the shampoo may result in the removal of curl from permanently waved hair. There is no other specific official guidance provided regarding potential effects on hair color or other chemical treatments.

Q: Where can I find the research evidence that supports the use of Ketozolin 2%?

The clinical evidence that supports the medication’s use and regulatory approval is contained within the official submission and review documents. These documents are typically published and maintained by government authorities such as the FDA and the EMA.

Q: What ingredients other than the active drug are in Ketozolin 2%?

The official product information lists all ingredients, including the active drug and the inactive components, which are known as excipients. Examples of these excipients include common components like sodium lauryl ether sulfate, disodium laureth sulfosuccinate, and purified water.

How should Ketozolin 2% be stored and disposed of?

Storage and Disposal Requirements for Ketozolin 2%

Official regulatory documents define the mandatory conditions for storing and disposing of Ketozolin 2% (ketoconazole 2% shampoo).

Storage Conditions

The product must be stored at room temperature, specifically not above 25 C (77 F), and must be protected from light. It is required to keep the medicine in the original container and ensure the container remains tightly closed when not in use. The medicine must not be frozen. For safety, the product must be stored out of the sight and reach of children.

Disposal Instructions

To prevent environmental contamination, unused or expired Ketozolin 2% must not be disposed of in household waste or flushed down the drain (wastewater). Disposal must follow specific instructions; patients are required to consult a pharmacist or local waste disposal authority for the correct procedure.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ketozolin 2% found in:

A-Z Index: